|
產(chǎn)品基本信息 |
|
產(chǎn)品編號(hào):D193604 |
產(chǎn)品名稱:Dasatinib-13C415N2 |
產(chǎn)品CAS:1107614-42-5 |
規(guī)格含量:2.5mg |
產(chǎn)品價(jià)格:面議 |
聯(lián)系我們: |
|
|
|
|
|
產(chǎn)品詳細(xì)介紹 |
標(biāo)準(zhǔn)品編號(hào): |
D193604 |
名稱: |
Dasatinib-13C415N2 |
別名: |
N-[2-Chloro-6-methylphenyl]-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide-13C415N2; BMS-354825-13C415N2; |
CAS號(hào): |
1107614-42-5 |
分子式: |
C??¹³C?H??ClN?¹?N?O?S |
分子量: |
493.96 |
種類: |
Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites; |
應(yīng)用: |
Isotope labelled Dasatinib (D193600), A new, oral, small-molecule Tyrosine Kinase Inhibitor (TKI) for the treatment of CML. Antineoplastic. |
參考文獻(xiàn) |
|
|
|
|